Page 2 - Fda

US FDA grants accelerated approval to Genfit, Ipsen's liver disease drug

Ipsen added that standard approval for Iqirvo may be contingent on confirmatory trials

FDA warns against infant formula by Texas firm due to contamination

US health officials warned parents to avoid powdered infant formula sold by a Texas dairy producer, because a dangerous bacteria was found in one of the company's products. The Food and Drug Administration issued the alert Friday on Crecelac Infant Powdered Goat Milk Infant Formula, after a sample collected from a Texas store tested positive for cronobacter, which can cause deadly infections in babies. The same bacteria sparked recalls and shortages of infant formula in 2022 after it was detected at a major US formula factory. The Crecelac formula was imported and distributed by Dairy Manufacturers Inc., of Prosper, Texas, according to the FDA. Press releases from the FDA and the company did not specify where the product was produced or how widely it was distributed in the US Messages left for the company on Friday were not immediately returned. Last week, the company voluntarily recalled the Crecelac formula and another brand, Farmalac, because they had not received approval by the

US drug regulator delaying decision on RSV vaccine approval, says Moderna

The FDA hasn't informed Moderna of any issues related to vaccine safety, efficacy or quality that would prevent approval, Moderna said Friday in a statement

Two fall sick after eating at Noida's McDonald's, Theobroma; probe on

FDA immediately took action and visited McDonald's at Noida Sector 18 to collect the samples

In 6 months, US rejected nearly one-third of MDH's spice-related shipments

Refusal rate over salmonella contamination doubles. When ingested, salmonella can lead to a severe stomach infection affecting the intestinal tract if food is not adequately cooked

FDA revokes licence of McDonald's store after action over cheese

The Maharashtra Food and Drug Administration (FDA) has revoked the licence of a McDonald's outlet in the state's Ahmednagar district after taking action against it over cheese, an official said on Saturday. The eatery belonging to the fast food giant had faced FDA scrutiny for allegedly using a cheese-like product in their dishes without indicating that it was actually a cheese substitute, thereby misleading customers, he said. Following an inspection and subsequent objections, the licence of the outlet was suspended, but it was revoked recently after the chain filed a compliance report confirming that they had removed the word cheese' from product names. In October 2023, we visited the outlet in Kedgaon and discovered that the names of food items displayed at the outlet included American Cheese Burger, American Cheese Nuggets, Cheese Burger, Italian Cheesy Lava Burger, and Blueberry Cheese Cake. All these names are their brand names for their products," said Rajendra Bade, a food .

McDonald's removes 'cheese' from its outlet menus in Maharashtra

Move comes after Maharashtra FDA accused chain of using cheese substitutes in burgers and nuggets

Maharashtra FDA cracks down on McDonald's for using substitutes for cheese

McDonald's has denied accusations of misleading consumers by using substitutes in place of real cheese in burgers and nuggets

US approves 1st vaccine against chikungunya virus: All you need to know

Symptoms of chikungunya can sometimes last for months or even years, but the virus is rarely fatal

Aurobindo Pharma arm receives FDA nod for Testosterone Cypionate injection

According to research firm IQVIA, the approved product has an estimated market size of $226.8 million for the twelve months ending August 2023

Lupin receives US regulator's approval for Cyanocobalamin nasal spray

The nasal spray manufactured by Lupin is a generic version of Nascobal nasal spray

Pharma major Lupin gets establishment inspection report from USFDA

Lupin Limited received an inspection classification of "No Action Indicated" (NAI) after the inspection, which was conducted between March 6 to March 10

Covid pill Paxlovid gets full FDA approval after a year of emergency use

Pfizer received full approval on Thursday for its COVID-19 pill Paxlovid that's been the go-to treatment against the coronavirus. More than 11 million prescriptions for Paxlovid have been dispensed since the Food and Drug Administration allowed emergency use in late 2021. The emergency status was based on early studies and was intended to be temporary pending follow-up research. The FDA granted full approval for adults with COVID-19 who face high risks of severe disease, which can lead to hospitalization or death. That group typically includes older adults and those with common medical conditions like diabetes, asthma and obesity. The decision allows Pfizer's drug to remain on the market indefinitely and to be marketed similarly to other drugs. The pill is still available for children ages 12 to 17 under a separate emergency authorisation. The US government has stockpiled millions of doses of Paxlovid and patients will continue to receive it at no charge, the FDA said in a stateme

FDA authorises combination flu-Covid test for home use to help consumers

The Food and Drug Administration on Friday approved the first combination test for flu and C OVID-19 that can be used at home, giving consumers an easy way to determine if a runny nose is caused by either disease. The Lucira COVID-19 & Flu Home test, which can be purchased without a prescription, uses self-collected nasal swab samples and delivers results in about 30 minutes, the agency said. While at-home COVID tests are readily available, this is the first home test for influenza A and B, commonly known as the flu. The test was granted an emergency use authorization, which facilitates the availability of medical countermeasures during public health emergencies. Jeff Shuren, director of the FDA's Center for Devices and Radiological Health, called the authorization a major milestone in bringing greater consumer access to diagnostic tests that can be performed entirely at home. The agency said the test is for individuals with signs and symptoms consistent with a respiratory tract ..

WHO stands by action of issuing alert against Maiden Pharma cough syrup

Asserts that testing done in labs in Ghana and Switzerland confirmed excess levels of contaminated syrups that are "dangerous and should not be in any medicine, ever"

'Patients cannot be forced to buy medicines from hospital-attached shops'

Patients cannot be compelled to purchase medicines from hospital-attached drug stores, the Maharashtra Food & Drug Administration (FDA) has said. A notification issued by Commissioner, FDA, Abhimanyu Kale said FDA had received repeated complaints that patients have been forced to buy medicines from the drug store in hospitals. "It is illegal for a hospital to force patients to buy medicines from their affiliated stores," said the notification, addressed to all the divisional joint commissioners, assistant commissioners, and drug inspectors (Drugs). Patients don't need to purchase medicines from hospital-affiliated shops and the same can be purchased from any licensed drug store, it said. The hospitals concerned should prominently display a signboard at a prominent place visible to the patients, as per the notification.

FDA takes action against 144 establishments since April in Maharashtra

A total of 175 establishments have been checked and action has been taken against 144 since April this year for various violations of rules and regulations, an official of the Konkan division of the Food and Drug Administration said on Friday. FDA Joint Commissioner Suresh Deshmukh said raids were conducted in Thane, Palghar, Raigad, Ratnagiri and Sindhudurg, which are part of the Konkan division. "Gutkha and tobacco products worth Rs. 2,92,01,518 were seized. At least 60 FIRs have been registered at various police stations. We have sealed 129 establishments and five vehicles have been confiscated," he said. "During 2021-22 a total of 105 establishments were inspected and action was taken against 99," he added.

Maha FDA asks drug controllers to stop Orofer FCM injection use

The Maharashtra Food & Drug Administration (FDA) has asked all drug controller authorities in the country to stop the use of a particular batch of drug INJ OROFER FCM following the death of a patient at a Mumbai hospital. A person died at Saifee Hospital in Mumbai due to suspected adverse drug reaction of the drug, said a senior official from FDA's Pune division on Wednesday. Orofer FCM injection is used to treat iron deficiency anaemia. Emcure Pharmaceuticals, the manufacturer, was asked to recall the particular batch of the drug, said S B Patil, Joint Commissioner (Drugs) FDA. The death of a person at Saifee Hospital was due to suspected adverse reaction of this drug, he said. As per the company, there could be spurious drugs available in the market in the name of INJ OROFER and because of such spurious drug the suspected adverse reaction might have taken place, he said. The company also told the FDA that spurious versions of one of its other drugs was already being sold ..

FDA approval for human consumption of lab-grown meat in the US

It's already possible to purchase some types of lab-grown meat in the world. Two years ago, Singapore became the first nation to approve the sale of cultivated meat

Cipla Q2 PAT up 11% PAT to Rs 789 cr on strong Covid-adjusted growth rate

The company is de-risking key product Abraxane in case the Goa plant FDA issue is not cleared immediately